Therapeutic advances in cardiovascular disease

Keyphrases

Publications

volume 18, 2024

Haytham Derbel, Mahdi Krichen, Youssef Zaarour, Salim Jazzar, Mario Ghosn, Vania Tacher, Hicham Kobeiter
Percutaneous image-guided management of a misplaced pericardiocentesis catheter into the inferior vena cava. Therapeutic advances in cardiovascular disease 18 (2024)
Mehrbod Vakhshoori, Niloofar Bondariyan, Sadeq Sabouhi, Keivan Kiani, Nazanin Alaei Faradonbeh, Sayed Ali Emami, Mehrnaz Shakarami, Farbod Khanizadeh, Shahin Sanaei, Niloofaralsadat Motamedi, Davood Shafie
The impact of platelet-to-lymphocyte ratio on clinical outcomes in heart failure: a systematic review and meta-analysis. Therapeutic advances in cardiovascular disease 18 (2024)
Ayan S Abdrakhmanov, Aizhana Shaimerdinova, Zhanasyl Suleimen, Svetlana Abildinova, Rustam Albayev, Gulnar Tuyakova, Elena Rib, Akmaral Beysenbayeva, Gulden Kabduyeva, Makhabbat Bekbossynova
Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants. Therapeutic advances in cardiovascular disease 18 (2024)
Yasusuke Kinoshita, Yuichi Saito, Yuetsu Kikuta, Katsumasa Sato, Masahito Taniguchi, Kenji Goto, Hideo Takebayashi, Seiichi Haruta, Yoshio Kobayashi
Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing. Therapeutic advances in cardiovascular disease 18 (2024)
Isabella Sudano, Stephan Krähenbühl, François Mach, Anne Anstett, Nafeesa Dhalwani, Ian Bridges, Mahendra Sibartie, Kausik K Ray
Evolocumab use in clinical practice in Switzerland: final data of the observational HEYMANS cohort study. Therapeutic advances in cardiovascular disease 18 (2024)
Ayan S Abdrakhmanov, Aizhana Shaimerdinova, Zhanasyl Suleimen, Svetlana Abildinova, Rustam Albayev, Gulnar Tuyakova, Elena Rib, Akmaral Beysenbayeva, Gulden Kabduyeva, Makhabbat Bekbossynova
Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants. Therapeutic advances in cardiovascular disease 18 (2024)
Ayan S Abdrakhmanov, Aizhana Shaimerdinova, Zhanasyl Suleimen, Svetlana Abildinova, Rustam Albayev, Gulnar Tuyakova, Elena Rib, Akmaral Beysenbayeva, Gulden Kabduyeva, Makhabbat Bekbossynova
Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants. Therapeutic advances in cardiovascular disease 18 (2024)
Yasusuke Kinoshita, Yuichi Saito, Yuetsu Kikuta, Katsumasa Sato, Masahito Taniguchi, Kenji Goto, Hideo Takebayashi, Seiichi Haruta, Yoshio Kobayashi
Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing. Therapeutic advances in cardiovascular disease 18 (2024)
Isabella Sudano, Stephan Krähenbühl, François Mach, Anne Anstett, Nafeesa Dhalwani, Ian Bridges, Mahendra Sibartie, Kausik K Ray
Evolocumab use in clinical practice in Switzerland: final data of the observational HEYMANS cohort study. Therapeutic advances in cardiovascular disease 18 (2024)
Maria Rita Lima, Pedro M Lopes, António M Ferreira
Use of coronary artery calcium score and coronary CT angiography to guide cardiovascular prevention and treatment. Therapeutic advances in cardiovascular disease 18 (2024)
Kenny Jenkins, Graziella Pompei, Nandine Ganzorig, Sarah Brown, John Beltrame, Vijay Kunadian
Vasospastic angina: a review on diagnostic approach and management. Therapeutic advances in cardiovascular disease 18 (2024)
Kai Zhang, Fangming Gu, Yu Han, Tianyi Cai, Zhaoxuan Gu, Jianguo Chen, Bowen Chen, Min Gao, Zhengyan Hou, Xiaoqi Yu, JiaYu Zhao, Yafang Gao, Jinyu Xie, Rui Hu, Tianzhou Liu, Bo Li
Association between dietary calcium intake and severe abdominal aorta calcification among American adults: a cross-sectional analysis of the National Health and Nutrition Examination Survey. Therapeutic advances in cardiovascular disease 18 (2024)
Amirreza Khalaji, Saba Mehrtabar, Armin Jabraeilipour, Nadia Doustar, Hamed Rahmani Youshanlouei, Amir Tahavvori, Payam Fattahi, Seyed Mohammad Amin Alavi, Seyed Reza Taha, Andarz Fazlollahpour-Naghibi, Mahdieh Shariat Zadeh
Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development. Therapeutic advances in cardiovascular disease 18 (2024)
Aashish Lamichhane, Sadish Sharma, Bishwas Bastola, Bikesh Chhusyabaga, Nabin Shrestha, Prajwal Poudel
Unlocking the potential of deferoxamine: a systematic review on its efficacy and safety in alleviating myocardial ischemia-reperfusion injury in adult patients following cardiopulmonary bypass compared to standard care. Therapeutic advances in cardiovascular disease 18 (2024)
Gowri Kiran Puvvala, Anastasios Psyllas, Jürgen Hinkelmann, Daniel Herzenstiel, Grigorios Korosoglou
Endovascular clot removal in small and tortuous arteries: a case series. Therapeutic advances in cardiovascular disease 18 (2024)
Khawaja M Talha, Talal Almas, Abdul Mannan Khan Minhas, Husam Salah, Adeena Jamil, Heather M Johnson, Vardhmaan Jain, Steve Antoine, Sadiya S Khan, Muhammad Shahzeb Khan
Disparities in heart failure between White, Black, and Hispanic young adults: insights from the National Health and Nutrition Examination Survey. Therapeutic advances in cardiovascular disease 18 (2024)
Maria Rita Lima, Pedro M Lopes, António M Ferreira
Use of coronary artery calcium score and coronary CT angiography to guide cardiovascular prevention and treatment. Therapeutic advances in cardiovascular disease 18 (2024)
Maria Rita Lima, Pedro M Lopes, António M Ferreira
Use of coronary artery calcium score and coronary CT angiography to guide cardiovascular prevention and treatment. Therapeutic advances in cardiovascular disease 18 (2024)
Ayan S Abdrakhmanov, Aizhana Shaimerdinova, Zhanasyl Suleimen, Svetlana Abildinova, Rustam Albayev, Gulnar Tuyakova, Elena Rib, Akmaral Beysenbayeva, Gulden Kabduyeva, Makhabbat Bekbossynova
Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants. Therapeutic advances in cardiovascular disease 18 (2024)
Khawaja M Talha, Talal Almas, Abdul Mannan Khan Minhas, Husam Salah, Adeena Jamil, Heather M Johnson, Vardhmaan Jain, Steve Antoine, Sadiya S Khan, Muhammad Shahzeb Khan
Disparities in heart failure between White, Black, and Hispanic young adults: insights from the National Health and Nutrition Examination Survey. Therapeutic advances in cardiovascular disease 18 (2024)
Khawaja M Talha, Talal Almas, Abdul Mannan Khan Minhas, Husam Salah, Adeena Jamil, Heather M Johnson, Vardhmaan Jain, Steve Antoine, Sadiya S Khan, Muhammad Shahzeb Khan
Disparities in heart failure between White, Black, and Hispanic young adults: insights from the National Health and Nutrition Examination Survey. Therapeutic advances in cardiovascular disease 18 (2024)
Isabella Sudano, Stephan Krähenbühl, François Mach, Anne Anstett, Nafeesa Dhalwani, Ian Bridges, Mahendra Sibartie, Kausik K Ray
Evolocumab use in clinical practice in Switzerland: final data of the observational HEYMANS cohort study. Therapeutic advances in cardiovascular disease 18 (2024)
Ankush Gupta, Abhinav Shrivastava, Jaskaran Singh Dugal, Sanya Chhikara, Rajesh Vijayvergiya, Navreet Singh, Ajit Chandrakant Mehta, Nalin Kumar Mahesh, Ajay Swamy
Coronary intravascular lithotripsy in contemporary practice: challenges and opportunities in coronary intervention. Therapeutic advances in cardiovascular disease 18 (2024)
Kai Zhang, Fangming Gu, Yu Han, Tianyi Cai, Zhaoxuan Gu, Jianguo Chen, Bowen Chen, Min Gao, Zhengyan Hou, Xiaoqi Yu, JiaYu Zhao, Yafang Gao, Jinyu Xie, Rui Hu, Tianzhou Liu, Bo Li
Association between dietary calcium intake and severe abdominal aorta calcification among American adults: a cross-sectional analysis of the National Health and Nutrition Examination Survey. Therapeutic advances in cardiovascular disease 18 (2024)
Amirreza Khalaji, Saba Mehrtabar, Armin Jabraeilipour, Nadia Doustar, Hamed Rahmani Youshanlouei, Amir Tahavvori, Payam Fattahi, Seyed Mohammad Amin Alavi, Seyed Reza Taha, Andarz Fazlollahpour-Naghibi, Mahdieh Shariat Zadeh
Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development. Therapeutic advances in cardiovascular disease 18 (2024)
Ankush Gupta, Abhinav Shrivastava, Jaskaran Singh Dugal, Sanya Chhikara, Rajesh Vijayvergiya, Navreet Singh, Ajit Chandrakant Mehta, Nalin Kumar Mahesh, Ajay Swamy
Coronary intravascular lithotripsy in contemporary practice: challenges and opportunities in coronary intervention. Therapeutic advances in cardiovascular disease 18 (2024)
Kai Zhang, Fangming Gu, Yu Han, Tianyi Cai, Zhaoxuan Gu, Jianguo Chen, Bowen Chen, Min Gao, Zhengyan Hou, Xiaoqi Yu, JiaYu Zhao, Yafang Gao, Jinyu Xie, Rui Hu, Tianzhou Liu, Bo Li
Association between dietary calcium intake and severe abdominal aorta calcification among American adults: a cross-sectional analysis of the National Health and Nutrition Examination Survey. Therapeutic advances in cardiovascular disease 18 (2024)
Amirreza Khalaji, Saba Mehrtabar, Armin Jabraeilipour, Nadia Doustar, Hamed Rahmani Youshanlouei, Amir Tahavvori, Payam Fattahi, Seyed Mohammad Amin Alavi, Seyed Reza Taha, Andarz Fazlollahpour-Naghibi, Mahdieh Shariat Zadeh
Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development. Therapeutic advances in cardiovascular disease 18 (2024)
Maria Rita Lima, Pedro M Lopes, António M Ferreira
Use of coronary artery calcium score and coronary CT angiography to guide cardiovascular prevention and treatment. Therapeutic advances in cardiovascular disease 18 (2024)
Haytham Derbel, Mahdi Krichen, Youssef Zaarour, Salim Jazzar, Mario Ghosn, Vania Tacher, Hicham Kobeiter
Percutaneous image-guided management of a misplaced pericardiocentesis catheter into the inferior vena cava. Therapeutic advances in cardiovascular disease 18 (2024)

volume 17, 2023

Arti Dhar, Jegadheeswari Venkadakrishnan, Utsa Roy, Sahithi Vedam, Nikita Lalwani, Kenneth S Ramos, Tej K Pandita, Audesh Bhat
A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy. Therapeutic advances in cardiovascular disease 17 (2023)
Chun Shing Kwok, William E Moody
The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis. Therapeutic advances in cardiovascular disease 17 (2023)
Prashanth Ganekal, Basavaraj Vastrad, Chanabasayya Vastrad, Shivakumar Kotrashetti
Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis. Therapeutic advances in cardiovascular disease 17 (2023)
Prashanth Ganekal, Basavaraj Vastrad, Chanabasayya Vastrad, Shivakumar Kotrashetti
Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis. Therapeutic advances in cardiovascular disease 17 (2023)
Merab Babirye, Tadele Mekuriya Yadesa, Robert Tamukong, Paul Stephen Obwoya
Prevalence and factors associated with drug therapy problems among hypertensive patients at hypertension clinic of Mbarara Regional Referral Hospital, Uganda: a |cross-sectional study. Therapeutic advances in cardiovascular disease 17 (2023)
Elmira Jafari Afshar, Parham Samimisedeh, Amirhossein Tayebi, Neda Shafiabadi Hassani, Hadith Rastad, Shahrooz Yazdani
Efficacy and safety of intracoronary epinephrine for the management of the no-reflow phenomenon following percutaneous coronary interventions: a systematic-review study. Therapeutic advances in cardiovascular disease 17 (2023)
Arduino Aleksander Mangoni, Salvatore Sotgia, Angelo Zinellu, Ciriaco Carru, Gianfranco Pintus, Giovanni Damiani, Gian Luca Erre, Sara Tommasi
Methotrexate and cardiovascular prevention: an appraisal of the current evidence. Therapeutic advances in cardiovascular disease 17 (2023)
Elmira Jafari Afshar, Parham Samimisedeh, Amirhossein Tayebi, Neda Shafiabadi Hassani, Hadith Rastad, Shahrooz Yazdani
Efficacy and safety of intracoronary epinephrine for the management of the no-reflow phenomenon following percutaneous coronary interventions: a systematic-review study. Therapeutic advances in cardiovascular disease 17 (2023)
Prashanth Ganekal, Basavaraj Vastrad, Chanabasayya Vastrad, Shivakumar Kotrashetti
Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis. Therapeutic advances in cardiovascular disease 17 (2023)
Arduino Aleksander Mangoni, Salvatore Sotgia, Angelo Zinellu, Ciriaco Carru, Gianfranco Pintus, Giovanni Damiani, Gian Luca Erre, Sara Tommasi
Methotrexate and cardiovascular prevention: an appraisal of the current evidence. Therapeutic advances in cardiovascular disease 17 (2023)
Chun Shing Kwok, William E Moody
The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis. Therapeutic advances in cardiovascular disease 17 (2023)
Yosuke Takei, Hiroyoshi Mori, Takahiro Tezuka, Ayumi Omura, Daisuke Wada, Hiromoto Sone, Kazuma Tashiro, Masahiro Sasai, Tokutada Sato, Hiroshi Suzuki
Neointimal characteristic changes following drug-coated balloons in lesions with repeated revascularization. Therapeutic advances in cardiovascular disease 17 (2023)
Faizus Sazzad, Zhi Xian Ong, Geok Seen Ong, Hai Dong Luo, Si Guim Goh, Theo Kofidis, Sorokin Vitaly
Non-selective Del Nido and St Thomas cardioplegia in adults: analysis of early clinical experience using propensity matching. Therapeutic advances in cardiovascular disease 17 (2023)
Patrick Ashinze, Toufik Abdul-Rahman, Andrew Awuah Wireko
The usage of SGLT-2 inhibitors in the management of heart failure in rural Africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure. Therapeutic advances in cardiovascular disease 17 (2023)
Alexander C Razavi, Sindhu Prabakaran, Mariem Sawan, Lakshmi Tummala, Ifeoma Onuorah, Sagar B Amin, Marly van Assen, Carlo N De Cecco, Arshed A Quyyumi, Seamus P Whelton, Laurence S Sperling, Francois G Rollin
Transient left bundle branch block associated with very high coronary artery calcium: a case report. Therapeutic advances in cardiovascular disease 17 (2023)
Arduino Aleksander Mangoni, Salvatore Sotgia, Angelo Zinellu, Ciriaco Carru, Gianfranco Pintus, Giovanni Damiani, Gian Luca Erre, Sara Tommasi
Methotrexate and cardiovascular prevention: an appraisal of the current evidence. Therapeutic advances in cardiovascular disease 17 (2023)
Giselle Del Calvo, Teresa Baggio Lopez, Anastasios Lymperopoulos
The therapeutic potential of targeting cardiac RGS4. Therapeutic advances in cardiovascular disease 17 (2023)
Borenyi S Seidu, Hanad Osman, Samuel Seidu
Lifestyle or pharmacotherapy in cardio-metabolic disease prevention. Therapeutic advances in cardiovascular disease 17 (2023)
Arti Dhar, Jegadheeswari Venkadakrishnan, Utsa Roy, Sahithi Vedam, Nikita Lalwani, Kenneth S Ramos, Tej K Pandita, Audesh Bhat
A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy. Therapeutic advances in cardiovascular disease 17 (2023)
Santosh Kumar Saha, Chaudhury Meshkat Ahmed, Tuhin Haque, Mohammad Abdullah Al Mamun, Mohd Zahid Hussain
Assessment of atrial septal defects using 3-dimensional transthoracic echocardiography prior to percutaneous device closure: first report from Bangladesh. Therapeutic advances in cardiovascular disease 17 (2023)